BioNTech SE (BNTX) Retained Earnings (2018 - 2025)
BioNTech SE (BNTX) posted Retained Earnings of $20.9 billion for Q4 2025, up 1305.75% sequentially from -$1.7 billion in Q3 2025, and up 2.45% YoY from $20.4 billion in Q4 2024.
BioNTech SE (BNTX) Retained Earnings (2018 - 2025) Analysis & Trends
BioNTech SE has reported Retained Earnings for 8 years, with the latest figure at $20.9 billion in Q4 2025.
- Quarterly Retained Earnings rose 2.45% year-over-year to $20.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.9 billion (up 2.45% YoY) and the FY2025 annual result came in at $20.3 billion, down 0.56% from the prior year.
- Retained Earnings grew to $20.9 billion in Q4 2025 per BNTX's latest filing, from -$1.7 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $20.9 billion in Q4 2025 and troughed at -$1.7 billion in Q3 2025.
- A 5-year average of $1.6 billion and a median of -$952.3 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings plunged 906.27% in 2022, then jumped 2026.43% in 2024.
- Over 5 years, Retained Earnings stood at $107.4 million in 2021, then slumped by 906.27% to -$866.1 million in 2022, then fell by 22.32% to -$1.1 billion in 2023, then soared by 2026.43% to $20.4 billion in 2024, then climbed by 2.45% to $20.9 billion in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered $20.9 billion, -$1.7 billion, and -$1.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 20.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.70 Bn |
| Sep 30, 2025 | -1.73 Bn |
| Jun 30, 2025 | -1.67 Bn |
| Mar 31, 2025 | -1.52 Bn |
| Dec 31, 2024 | -1.42 Bn |
| Sep 30, 2024 | -1.47 Bn |
| Jun 30, 2024 | -1.12 Bn |
| Mar 31, 2024 | -1.03 Bn |
| Dec 31, 2023 | -1.06 Bn |
| Sep 30, 2023 | -984.96 Mn |
| Jun 30, 2023 | -982.75 Mn |
| Mar 31, 2023 | -921.79 Mn |
| Dec 31, 2022 | -866.09 Mn |
| Sep 30, 2022 | 527.63 Mn |
| Jun 30, 2022 | 137.44 Mn |
| Mar 31, 2022 | 123.12 Mn |
| Dec 31, 2021 | 107.42 Mn |
| Mar 31, 2021 | 54.40 Mn |
| Dec 31, 2020 | 488.36 Mn |
| Dec 31, 2019 | 5.34 Mn |